Literature DB >> 19698659

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms.

K Yoshida1, T Sugita, H Higuchi, Y Hishikawa.   

Abstract

The authors examined the effect of tandospirone on tardive dyskinesia (TD) and parkinsonian symptoms in an open study. Tandospirone did not bring about any favourable effect on TD, but it had a good effect on the parkinsonian symptoms.

Entities:  

Year:  1998        PMID： 19698659     DOI： 10.1016/S0924-9338(99)80690-7

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN： 0924-9338            Impact factor:   5.361


  7 in total

1.  In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

Authors:  Marie-Bernadette Assié; Hélène Dominguez; Nathalie Consul-Denjean; Adrian Newman-Tancredi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-01       Impact factor: 3.000

2.  F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.

Authors:  R Depoortère; L Bardin; A L Auclair; M S Kleven; E Prinssen; F Colpaert; B Vacher; A Newman-Tancredi
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 3.  Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Authors:  Kathryn Lanza; Christopher Bishop
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

4.  8-OH-DPAT enhances dopamine D2-induced maternal disruption in rats.

Authors:  Yongjian Cai; Xinyue Zhang; Tianyi Jiang; Haocheng Zhong; Xingchen Han; Rui Ma; Ruiyong Wu
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2022-04-17       Impact factor: 2.389

5.  Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats.

Authors:  Danuta Marona-Lewicka; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

Review 6.  Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Authors:  Xuefei Huang; Jing Yang; Sijin Yang; Shousong Cao; Dalian Qin; Ya Zhou; Xiaoli Li; Yun Ye; Jianming Wu
Journal:  Oncotarget       Date:  2017-10-27

7.  Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.

Authors:  Agnès L Auclair; Alexandra Galinier; Joël Besnard; Adrian Newman-Tancredi; Ronan Depoortère
Journal:  Psychopharmacology (Berl)       Date:  2007-03-29       Impact factor: 4.415
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.